Harmony Biosciences Holdings, Inc.
HRMY
$35.54
$1.143.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 506.95M | 467.19M | 410.48M | 346.91M | 372.35M |
| Total Receivables | 105.97M | 83.03M | 81.50M | 83.16M | 79.72M |
| Inventory | 6.38M | 7.20M | 6.92M | 5.64M | 5.86M |
| Prepaid Expenses | 16.47M | 13.71M | 16.06M | 16.13M | 12.89M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.92M | 8.12M | 7.46M | 6.51M | 8.68M |
| Total Current Assets | 642.69M | 579.25M | 522.41M | 458.34M | 479.50M |
|
|
|||||
| Total Current Assets | 642.69M | 579.25M | 522.41M | 458.34M | 479.50M |
| Net Property, Plant & Equipment | 3.10M | 3.38M | 3.07M | 3.26M | 3.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 107.30M | 113.26M | 119.23M | 125.19M | 131.15M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 199.19M | 194.43M | 189.21M | 184.41M | 151.83M |
| Total Assets | 1.06B | 999.20M | 928.14M | 858.38M | 846.99M |
|
|
|||||
| Total Accounts Payable | 17.46M | 13.74M | 10.53M | 22.68M | 15.14M |
| Total Accrued Expenses | 120.28M | 139.42M | 122.90M | 101.29M | 99.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.65M | 17.57M | 16.53M | 16.79M | 16.79M |
| Total Finance Division Other Current Liabilities | 18.73M | 4.35M | 11.32M | 5.83M | 23.30M |
| Total Other Current Liabilities | 18.73M | 4.35M | 11.32M | 5.83M | 23.30M |
| Total Current Liabilities | 175.12M | 175.08M | 161.28M | 146.58M | 154.25M |
|
|
|||||
| Total Current Liabilities | 175.12M | 175.08M | 161.28M | 146.58M | 154.25M |
| Long-Term Debt | 158.18M | 163.02M | 167.85M | 171.42M | 175.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 634.00K | 822.00K | 863.00K | 854.00K | 1.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.08M | 1.13M | 1.34M | 942.00K | 1.07M |
| Total Liabilities | 335.01M | 340.05M | 331.33M | 319.80M | 331.59M |
|
|
|||||
| Common Stock & APIC | 672.50M | 656.87M | 643.56M | 632.17M | 620.51M |
| Retained Earnings | 47.78M | 2.22M | -47.26M | -93.35M | -104.94M |
| Treasury Stock & Other | 245.00K | 66.00K | 499.00K | -234.00K | -171.00K |
| Total Common Equity | 720.53M | 659.16M | 596.80M | 538.58M | 515.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 720.53M | 659.16M | 596.80M | 538.58M | 515.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 720.53M | 659.16M | 596.80M | 538.58M | 515.39M |
|
|
|||||